SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Francois Goelo who wrote (10156)9/11/2006 12:35:57 PM
From: StockDung  Read Replies (3) of 19428
 
U.S. Marshals Seize Dietary Supplements At AMA's Request

September 11, 2006 11:15 a.m. EST

Patricia Shehan - All Headline News Staff Writer
Rockville, MD (AHN) - According to a recent press release, the United States Food and Drug Administration (U.S. FDA) requested the U.S. Marshals to seize the dietary supplements being distributed by a Fort Walton Beach, FL company, Advantage Nutraceuticals, L.L.C. The company allegedly made false claims of these supplements through mislabeling and promotional marketing.

The seized drugs, Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules and Advanced Arthritis Support capsules had an approximate value of $55,000.

The alleged false claims of these products were promoted through the drugs labels, literature, audio cassette tapes, and a couple of Internet websites. It is believed that these claims are in violation of the "new drug and misbranding provisions" of the Federal Food, Drug and Cosmetic Act.

The company was promoting these supplements to aid with serious diseases, such as cancer, arthritis and seizures without FDA approval.

An ongoing investigation of the company is being carried out, and the FDA warns consumers to consult with their physicians before taking any products such as these.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext